FF-10850 Topotecan Liposome Injection

liposomal topotecan · Fujifilm Pharmaceuticals U.S.A., Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FF-10850 Topotecan Liposome Injection, covering 2025-09-04 to 2025-09-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell Carcinoma [Phase 1]

See pricing